Status
Conditions
About
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
Full description
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease(IHD). Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion criteria :
Exclusion Criteria:
Loading...
Central trial contact
Yuan Wang, PhD; Yangkai Fan, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal